Clinical trial
Safety and Efficacy Study of APD125 in Patient With Insomnia
NCT00452179 · Arena Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00452179 |
|---|---|
| Title | Safety and Efficacy Study of APD125 in Patient With Insomnia |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, 3-Way Cross-Over Study to Evaluate the Effects of APD125 in Patients With Chronic Primary Insomnia |
| Lead sponsor | Arena Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | APD125 |
| Enrollment | 173 |
| Start date | Feb 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Mar 27, 2007 |
| Last update posted | Sep 10, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: